Oramed Pharmaceuticals Inc (ORMP) — Cash Flow-to-Debt Ratio
Oramed Pharmaceuticals Inc (ORMP) has a Cash Flow-to-Debt Ratio of -0.10x as of March 2026, meaning its operating cash flow of $-2.92 Million could theoretically repay 0% of its total liabilities ($30.57 Million) in one year. See ORMP financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Oramed Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Oramed Pharmaceuticals Inc across 22 annual periods. For the full cash flow conversion analysis, see Oramed Pharmaceuticals Inc cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Oramed Pharmaceuticals Inc (2003–2025)
Year-by-year debt coverage analysis for Oramed Pharmaceuticals Inc. Check Oramed Pharmaceuticals Inc cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.29x | $-9.14 Million | $31.12 Million | ▲ +65.3% |
| 2024 | -0.85x | $-8.41 Million | $9.93 Million | ▼ -374.4% |
| 2023 | -0.18x | $-10.29 Million | $57.66 Million | ▲ +93.5% |
| 2022 | -2.74x | $-28.70 Million | $10.49 Million | ▼ -48.4% |
| 2021 | -1.84x | $-21.18 Million | $11.48 Million | ▼ -74.3% |
| 2020 | -1.06x | $-12.44 Million | $11.75 Million | ▼ -24.9% |
| 2019 | -0.85x | $-12.94 Million | $15.27 Million | ▲ +5.8% |
| 2018 | -0.90x | $-14.66 Million | $16.29 Million | ▼ -200.6% |
| 2017 | -0.30x | $-5.83 Million | $19.47 Million | ▼ -207.0% |
| 2016 | 0.28x | $4.66 Million | $16.64 Million | ▲ +108.6% |
| 2015 | -3.24x | $-4.95 Million | $1.53 Million | ▲ +19.6% |
| 2014 | -4.03x | $-4.07 Million | $1.01 Million | ▲ +37.1% |
| 2013 | -6.41x | $-3.40 Million | $529.41K | ▼ -322.7% |
| 2012 | -1.52x | $-2.30 Million | $1.52 Million | ▲ +45.2% |
| 2011 | -2.77x | $-1.67 Million | $602.02K | ▼ -21.1% |
| 2010 | -2.29x | $-1.42 Million | $620.62K | ▲ +47.7% |
| 2009 | -4.37x | $-2.25 Million | $515.66K | ▼ -117.4% |
| 2008 | -2.01x | $-1.84 Million | $913.95K | ▼ -368.4% |
| 2007 | -0.43x | $-611.00K | $1.42 Million | ▲ +27.7% |
| 2006 | -0.59x | $-361.61K | $608.91K | ▲ +32.3% |
| 2005 | -0.88x | $-40.44K | $46.07K | ▲ +78.1% |
| 2003 | -4.00x | $-40.00K | $10.00K | — |